Azitra will present two oral presentations at ASGCT ( American Society of Gene and Cell Therapy ) Baltimore, MD , May 7-11, 2024 related to ATR-12, Azitra’s candidate for Netherton syndrome Topical application of ATR-12 to ex vivo human skin demonstrates the potential for superior LEKTI delivery
ASGCT ( American Society of Gene and Cell Therapy ) Baltimore, MD , May 7-11, 2024 SID ( Society of Investigative Dermatology ) Dallas, TX , May 15-18, 2024 ASCO ( American Society of Clinical Oncology ) Chicago, IL , May 31 – June 4, 2024 BRANFORD, Conn. --(BUSINESS WIRE)--Apr.
BRANFORD, Conn. --(BUSINESS WIRE)--Mar. 15, 2024-- Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today reported financial results for the full year ended December 31, 2023 , and provided a
BRANFORD, Conn. --(BUSINESS WIRE)--Feb. 16, 2024-- Azitra, Inc. (NYSE American: AZTR) (the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced the closing of its previously announced public offering of
BRANFORD, Conn. --(BUSINESS WIRE)--Feb. 13, 2024-- Azitra, Inc. (NYSE American: AZTR) (“Company”), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced the pricing of an underwritten public offering of 16,667,000 shares of
Newly granted patent protects a filaggrin-secreting strain of Staphylococcus epidermidis for the treatment of ichthyosis vulgaris Ichthyosis vulgaris is a high unmet need with no FDA-approved treatment option and affects approximately 1.3 million people in the United States Broadens Azitra’s
BRANFORD, Conn. --(BUSINESS WIRE)--Jan. 3, 2024-- Azitra, Inc . (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that management will present at the Dermatology Summit 2024 , on Sunday, January 7,